Overview

Anastrozole 1 mg Tablets Under Fed Conditions

Status:
Completed

Trial end date:
2005-10-01

Target enrollment:

Participant gender:

Summary

The objective of this study is to evaluate the comparative bioavailability between Anastrozole 1 mg Tablets (Teva Pharmaceuticals, USA) and Arimidex® 1 mg Tablets (AstraZeneca Pharmaceuticals LP, USA), after a single-dose in healthy subjects under fed conditions.

Phase:

Phase 1

Details

Lead Sponsor:

Teva Pharmaceuticals USA

Treatments:

Anastrozole